An observational study in Intensive Care (ICU), sponsored by Tepecik Training and Research Hospital. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-29.
Sponsored by Tepecik Training and Research Hospital · Observational
his study evaluates the diagnostic accuracy of bedside gastric ultrasonography for confirmation of nasogastric tube placement in intensive care unit patients, using chest radiography as the reference standard. Sensitivity and specificity of bedside ultrasonography will be calculated to assess its performance in this clinical setting.
Tepecik Training and Research Hospital is the lead sponsor of 33 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population consists of adult patients (aged 18 years and older) admitted to the intensive care unit who have a clinical indication for nasogastric tube placement. Eligible patients are enrolled prospectively following written informed consent obtained from the patient or a legally authorized representative.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age ≥ 18 years
Clinical indication for nasogastric tube placement
Written obtained from the patient or a legally authorized representative
Exclusion Criteria:
Age \< 18 years
Pregnancy
to nasogastric tube placement, including:
Facial trauma
Basilar skull fracture
Esophageal obstruction
Recent upper gastrointestinal surgery
Presence of wounds, burns, or surgical dressings in the epigastric region that preclude adequate ultrasonographic evaluation
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Diagnostic accuracy of bedside gastric ultrasonography for confirmation of nasogastric tube placement
Diagnostic accuracy of bedside gastric ultrasonography will be assessed by calculating sensitivity and specificity using chest radiography as the reference standard.
Time frame: Immediately after nasogastric tube placement
Agreement between bedside gastric ultrasonography and chest radiography
The level of agreement between bedside gastric ultrasonography and chest radiography findings will be evaluated.
Time frame: Immediately after nasogastric tube placement
Time to confirmation of nasogastric tube placement
Time required to confirm correct nasogastric tube placement using bedside gastric ultrasonography and chest radiography.
Time frame: From tube insertion to confirmation
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jan 2026; primary completion for Jul 2026, 6 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tepecik Training and Research Hospital